K160990

Substantially Equivalent

Nova Max Uric Acid Monitoring System

Applicant: Nova Biomedical Corporation
Product code: PTC
Advisory panel: Clinical Chemistry
Date received: 2016-04-08
Decision date: 2017-04-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Walham, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.